Young Research Fellows Meeting

Since 1994, the Young Research Fellows Meeting YRFM brings together each year about 300 young European scientists. This meeting gives the Young Fellows the opportunity to present their most recent results either through oral communications, flash presentations and/or posters. The topics presented cover all aspects of medicinal chemistry, chemical biology, chemoinformatics, SAR studies, ADMET, imaging,  physical  chemistry, biolabeling  and  diagnostic tools, drug vectorization, nanotechnologies, natural products, synthetic methodologies, etc... Senior and mid-career scientists, including the recipients of the Young Investigator in Medicinal Chemistry (Industry or Academia) provide inspiring talks. Along with scientific sessions, individual career sessions are organize to help the young fellows for their career.

Next edition: 31th YRFM, Feb.22nd-23rd 2024 Grenoble

News


You can download the final program here


Registration here 


Location

  • School of Pharmacy, Grenoble, France.

Date

  • February 22nd-23rd 2024.

Registration

  • Registration link
  • Deadline for registration is January 31 2024.
  • Registration fees : 50 EUR (Payment is mandatory for validation of your registration).
  • Submitted abstracts for oral communications / flash poster communications will be peer-reviewed before acceptance, fee payment is mandatory for  abstract  peer  reviewing. All abstracts submitted for poster sessions will be accepted.
  • Once registered please use the link received in the email to upload your abstract.

 Confirmed speakers

  • Dr. Pauline POINOT, University of Poitiers

    Title : Induced-volatolomics for the exploration of biological processes.
  • Dr. Samir MESSAOUDI, University Paris Saclay

    Title : Innovative catalytic strategies for carbohydrate functionalization: applications in bioactive molecule synthesis.

  • Dr. Emmanuelle DUBOST, University of Caen

    Title : Design and synthesis of molecular hosts cryptophanes- application in imaging.
  • Dr. Laurent MEIJER, Perha Pharmaceuticals

    Title : Leucettinib-21, a DYRK1A kinase inhibitor drug candidate aiming at the correction of cognitive disorders in people with Down syndrome or Alzheimer’s disease.
  • Dr. Viet-Khoa TRAN NGUYEN, University Paris Cité

    Title : A practical guide to machine-learning scoring for structure-based virtual screening.

  • Dr. Rachid BENHIDA, Institut de Chimie de Nice

    Title : From artificial nucleic acids to small bioactive molecules.

  • Dr. Cyrille BOTTE, Institute of Advanced Biosciences, Grenoble.

    Title : Using mass spectrometry-based lipidomics to dissect host-pathogens metabolic interactions.

  • Prof. Emerson F. QUEIROZ, University of Geneva

    Title : From the discovery of bioactive natural products to the development of innovative strategies for their chemo-diversification and generation of potential new leads.

Awards

  • The best oral communications/ flash poster communications will be awarded allowing young scientists to attend a future SCT meeting.

Individual career sessions

  • Registration for individual interview with representatives of human resources managers from major  pharmaceutical  companies  as  well  as  from  CRPs and start -ups (simulated  job  interviews, analysis of your CV...) are available.

Housing

  • SCT aims at promoting excellence in drug discovery in the largest audience. ln line with this consideration, low -cost rooms are available on our web site, and you can book a double room for 2 nights at a prefered rate.

Contact

  • Please feel free to contact the organizing committee,
Program